Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
Clinical trial NCT02827708 · COMPLETED
Trial details
- NCT number
- NCT02827708
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-20
- Primary completion
- 2018-04-10
- Enrollment
- 324
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.